TinyGemsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Real-World Data Highlighting Widespread Opioid Use Among Fibromyalgia Patients
Tonix Pharmaceuticals (NASDAQ: TNXP) presented data at the 2026 American Society of Clinical Psychopharmacology Annual Meeting showing that opioid use remains common among U.S. adults diagnosed with fibromyalgia despite longstanding treatment guidelines discouraging their use. Based on a retrospective analysis of more than 261,000 patients in the Symphony Health claims database, the study found that approximately 40% of commercially insured, Medicare Advantage and Medicaid patients with fibromyalgia were prescribed at least one opioid, with tramadol and oxycodone representing the most common prescriptions. Tonix said the findings underscore a gap between clinical practice and evidence-based recommendations and highlight the need for…
